Autoimmune polyglandular syndromes: clinical aspects

Česká verzia

Authors: K. Vondra
Authors place of work: Endokrinologický ústav Praha, ředitel doc. MUDr. Vojtěch Hainer, CSc.
Published in the journal: Vnitř Lék 2007; 53(7-8): 804-806
Category:

Summary

The history of autoimmune polyglandular syndromes (APS) and the basic characteristics of types 1 and 2 are briefly introduced. The clinical aspects of the more common type 2 are discussed in more detail from the point of view of the endocrinological and diabetological practice. The diagnosis aspects of preclinical, subclinical and manifestation stage of the main diseases occurring along with APS are briefly mentioned as well as the treatments and their challenges cause by the combination of various endocrine and non-endocrine autoimmune diseases. It is emphasized that care for there patients is a life-long process and that the health condition of these patients is usually very complicated. In some cases the combination of various disease conditions can make these patients completely disabled.

Key words:
autoimmune polyglandular syndromes – diabetes mellitus type 1 – autoimmune tyroiditis – Addison’s disease

Zdroje

1. Maclaren NK. Autoimmune polyglandular syndromes In: DeGroot LJ, Jameson JL (eds). Endocrinology. 5th Edition. Philadelphia (PA): Elsevier Saunders 2006: 819-836.

2. Dvořáková K, Vondra K. Asociované imunoendokrinopatie a genetika. In: Stárka L. Pokroky v endokrinologii. Praha: Maxdorf 2007: 240-253.

3. Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes. Immunogenetics and long- term follow-up. J Clin Endocrinol Metab 2003; 88: 2983-2992.

4. Vondra K, Vrbíková J, Bendlová B et al. Differences in Type I diabetes mellitus of young adults with and without thyroid autoimmunity. Exp Clin Endocrinol Diabetes 2005; 113: 404-408.

5. Vondra K, Vrbíková J, Sterzl I et al. Tyroidální autoimunita u dospělých diabetiků 1. typu. Vlastní zkušenosti z 11letého sledování. Vnitř Lék 2006; 52: 864-872.

6. Kunishige M, Sekimoto E, Komatsu M et al. Thyrotoxicosis masked by diabetic ketoacidosis. Diabetes Care 2001; 24: 171.

7. Vondra K, Zamrazil V. Endokrinní systém a diabetes mellitus. In: Blahoš J, Zamrazil V (eds). Endokrinologie. Interdisciplinární obor. Praha: Triton 2006: 353-366.

8. Zamrazil V, Vondra K. Endokrinní onemocnění u diabetiků. In: Perušičová J. Trendy soudobé diabetologie. Praha: Galén 2004,Vol 9: 11-28.

9. Vondra K, Hampl R. Glukokortikoidy a diabetes mellitus. Vnitř Lék 2006; 52: 493-497.

10. Mohn A, Di Michele S, Di Luzio R et al. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus. Diabet Med 2002; 19: 70-73.

11. Giordano R, Pellegrino M, Oleandri S et al. Adrenal sensitivity to adrenocorticotropin 1-24 is reduced in patients with autoimmune polyglandular syndrome. J Clin Metab 2004; 89: 675-680.

12. Kalmann R, Mourits MP. Diabetes mellitus: a risk factor in patients with Graves’ orbitopathy. Br J Ophthalmol 1999; 83: 463-465.

13. Salátová M, Vondra K. Autoimunitní polyglandulární syndrom 2. typu v ordinaci praktického lékaře. Prakt Lék 2007; 87: 169-172.